Business
Ocumetics Completes Manufacturing of Lenses to be used in First-in-Human Study
(TheNewswire) Calgary, Alberta – TheNewswire - May 14, 2025 - Ocumetics ...
About this update from Ocumetics Technology Corp
[{"type":"text","content":"Ocumetics Completes Manufacturing of Lenses to be used in First-in-Human Study\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, Alberta –\n \n\n TheNewswire -\n \n\n May 14, 2025\n \n\n -\nOcumetics Technology Corp\n \n\n .\n \n\n (“Ocumetics” or the “Company”)\n(TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced\nophthalmic technology, is pleased to announce it has successfully\n \n\n manufactured its inaugural accommodating\nintraocular lenses (the “Ocumetics Lens”) for use in its upcoming\nfirst-in-human (FIH) clinical study planned for summer 2025. Each\nOcumetics Lens produced has demonstrated, using the IOLA lens\nanalyzer, consistent quality and precision in alignment with study\nrequirements and stringent clinical standards.\n \n\n\n\n Dean Burns, President and CEO of Ocumetics, stated:\n“Our international design teams have worked diligently to refine and\nvalidate our production protocols. I’m confident that the\nmanufacturing processes developed by our team will deliver the\nconsistency in lens quality that is not only essential for clinical\ntrial success but also vital to Ocumetics’ long-term vision of\ncommercial scalability. This is a proud moment for the team as we\nprepare to deliver a transformative technology into clinical\nuse.”\n \n\n\n\n The Ocumetics Lenses, developed from the finalized\nprototype design, were manufactured under controlled conditions and\nsubjected to a comprehensive ISO quality assurance process. IOLA test\nresults confirm the reproducibility and stability of the lens\ncharacteristics, including the proprietary optical profile and\naccommodative mechanics, ensuring reliability for human\nimplantation.\n \n\n\n\n Dr. Garth Webb, Founder and Chief Scientific Officer\nof Ocumetics, shared his enthusiasm: “Achieving consistent quality\nacross manufactured lenses is a critical benchmark. It reinforces our\nbelief in the robustness of our design and the integrity of our\nmanufacturing processes. This step brings us closer to realizing the\npromise of restoring dynamic, natural vision for patients.”\n \n\n\n\n Manufacturing and validation were performed at the\nBioana laboratory in Mexico, supported by verifications at AMIPLANT,\nGermany. These activities are...